Wall Street brokerages predict that Omega Healthcare Investors Inc (NYSE:OHI) will post sales of $219.07 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Omega Healthcare Investors’ earnings, with the highest sales estimate coming in at $220.99 million and the lowest estimate coming in at $217.60 million. Omega Healthcare Investors posted sales of $234.49 million during the same quarter last year, which would indicate a negative year over year growth rate of 6.6%. The business is scheduled to announce its next quarterly earnings report on Wednesday, February 14th.

According to Zacks, analysts expect that Omega Healthcare Investors will report full-year sales of $219.07 million for the current year, with estimates ranging from $905.04 million to $936.00 million. For the next year, analysts expect that the firm will report sales of $929.88 million per share, with estimates ranging from $886.01 million to $958.00 million. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Omega Healthcare Investors.

Several research firms have recently weighed in on OHI. Hilliard Lyons cut shares of Omega Healthcare Investors to a “buy” rating in a report on Wednesday, November 1st. Capital One Financial reiterated an “equal weight” rating on shares of Omega Healthcare Investors in a report on Sunday, October 22nd. ValuEngine upgraded shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Friday, December 15th. Vetr cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 price target for the company. in a report on Monday, October 30th. Finally, Zacks Investment Research cut shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Thursday, September 28th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $32.14.

In other Omega Healthcare Investors news, Director Craig R. Callen acquired 10,000 shares of the business’s stock in a transaction dated Thursday, November 2nd. The shares were acquired at an average price of $27.38 per share, with a total value of $273,800.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bernard J. Korman acquired 100,000 shares of the business’s stock in a transaction dated Tuesday, October 31st. The stock was acquired at an average cost of $28.24 per share, for a total transaction of $2,824,000.00. Following the transaction, the director now owns 903,895 shares of the company’s stock, valued at $25,525,994.80. The disclosure for this purchase can be found here. Insiders own 1.54% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of OHI. Bronfman E.L. Rothschild L.P. raised its position in Omega Healthcare Investors by 167.7% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,432 shares of the real estate investment trust’s stock worth $113,000 after acquiring an additional 2,150 shares in the last quarter. Ffcm LLC raised its position in Omega Healthcare Investors by 197.6% during the second quarter. Ffcm LLC now owns 3,402 shares of the real estate investment trust’s stock worth $115,000 after acquiring an additional 2,259 shares in the last quarter. Barnett & Company Inc. raised its position in Omega Healthcare Investors by 1,980.0% during the third quarter. Barnett & Company Inc. now owns 5,200 shares of the real estate investment trust’s stock worth $166,000 after acquiring an additional 4,950 shares in the last quarter. Mcmillion Capital Management Inc. bought a new stake in Omega Healthcare Investors during the third quarter worth $201,000. Finally, Timber Hill LLC bought a new stake in Omega Healthcare Investors during the third quarter worth $206,000. 67.95% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors (NYSE OHI) opened at $27.10 on Thursday. The firm has a market cap of $5,350.00, a P/E ratio of 8.36, a PEG ratio of 2.95 and a beta of 0.49. Omega Healthcare Investors has a 1-year low of $26.43 and a 1-year high of $35.14. The company has a quick ratio of 3.40, a current ratio of 3.40 and a debt-to-equity ratio of 1.18.

ILLEGAL ACTIVITY WARNING: “Analysts Anticipate Omega Healthcare Investors Inc (OHI) Will Post Quarterly Sales of $219.07 Million” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/12/21/analysts-anticipate-omega-healthcare-investors-inc-ohi-will-post-quarterly-sales-of-219-07-million.html.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.